Trial
NCT01428154
Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Anemia
Intervention
Darbepoetin alfa
Why stopped
Difficulty in recruitment. PDCO in the Day 30 summary report agrred to remove the PK study in children \<1 year of age.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-17